Table 2.
Type of advertisement | Number of websites |
---|---|
Assisted hatching | |
Improves implantation chances/rates | 9 |
Improves pregnancy/clinical pregnancy chances/rates | 5 |
Evidence-based studies | 7 |
Insufficient/no evidence | 1 |
Reference to possible negative impact (e.g. on live birth) | 0 |
Time-lapse embryo imaging | |
Improves IVF success rates | 11 |
Improves clinical outcomes | 3 |
Improves implantation chances/rates | 12 |
Improves/increases ongoing pregnancy chances/rates | 21 |
Evidence-based studies/research/RCT | 22 |
Reference of studies | 3 |
Insufficient/no evidence | 4 |
Improves embryo selection – selection of ‘highest potential’ embryo | 30 |
Improves embryo culture and manipulation conditions | 8 |
Significant reduction of miscarriage/early pregnancy loss rates | 10 |
Higher percentage of genetically normal blastocysts – improves embryo potential | 8 |
Increases live birth rate | 3 |
Reduces preterm birth and very low birth weight | 1 |
Improves birth rates | 1 |
Supports better embryo development | 11 |
Reference to possible negative impact (e.g. on live birth) | 0 |
PGT-A | |
Improves pregnancy rates/likelihood | 15 |
Improves live birth rates | 5 |
Improves implantation rates | 5 |
Evidence-based studies/research | 7 |
Reference of studies | 2 |
Improves IVF success rates | 4 |
Reduces chance of miscarriage/minimizes chance of poor outcome | 10 |
Increases chance of having a healthy baby | 3 |
Does not increase overall chance of having a baby/no guarantee of a pregnancy | 2 |
Reference to possible negative impact (e.g. on live birth) | 0 |
PGT-A, preimplantation genetic testing for aneuploidies; RCT, randomized controlled trial.